Thai Nondestructive Testing Valuation
Is TNDT-W1-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of TNDT-W1-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: TNDT-W1-R (THB0.04) is trading above our estimate of fair value (THB0.01)
Significantly Below Fair Value: TNDT-W1-R is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for TNDT-W1-R?
Other financial metrics that can be useful for relative valuation.
What is TNDT-W1-R's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | n/a |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2.8x |
Enterprise Value/EBITDA | 29.8x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does TNDT-W1-R's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 2.4x | ||
K Kingsmen C.M.T.I | 0.8x | n/a | ฿708.7m |
PEER Peer For You | 0.6x | n/a | ฿348.1m |
KWC Krungdhep Sophon | 6.1x | n/a | ฿2.2b |
CHAYO Chayo Group | 2x | 11.0% | ฿3.6b |
TNDT-W1-R Thai Nondestructive Testing | 1.6x | n/a | ฿502.2m |
Price-To-Sales vs Peers: TNDT-W1-R is good value based on its Price-To-Sales Ratio (1.6x) compared to the peer average (2.4x).
Price to Earnings Ratio vs Industry
How does TNDT-W1-R's PE Ratio compare vs other companies in the Asian Commercial Services Industry?
Price-To-Sales vs Industry: TNDT-W1-R is expensive based on its Price-To-Sales Ratio (1.6x) compared to the Asian Commercial Services industry average (1.2x).
Price to Sales Ratio vs Fair Ratio
What is TNDT-W1-R's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 1.6x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate TNDT-W1-R's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.